Investor Relations

Corporate Profile

Arcutis Biotherapeutics (NASDAQ: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.

The company’s strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders.

Latest Quarterly Earnings

There are no quarterly results available at this time.
Print Page
RSS Feeds
Email Alerts
Search